Herrick Well

Dustin Crandall, Brian Panetta, Timothy R. Carr, Sarah Brown(University of Leeds), Johnathan Moore

OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)

January 1, 2018

10.18141/1887578

Cited by 0

Related Papers

Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial

|The Lancet|2010|640

Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial

|The Lancet|2015|477

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

|The Lancet Oncology|2013|392

Clinical development of new drug–radiotherapy combinations

|Nature Reviews Clinical Oncology|2016|317

<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trials

|The Journal of Pathology|2015|238